Exact Mass: 692.3619026

Exact Mass Matches: 692.3619026

Found 41 metabolites which its exact mass value is equals to given mass value 692.3619026, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Bismahanine

15-[9-hydroxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-3H,11H-pyrano[3,2-a]carbazol-8-yl]-5,8-dimethyl-5-(4-methylpent-3-en-1-yl)-6-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1,3,7,9,11(16),12,14-heptaen-14-ol

C46H48N2O4 (692.3613888)

Bismahanine is found in herbs and spices. Bismahanine is an alkaloid from the stem bark of Murraya koenigii (curryleaf tree). Alkaloid from the stem bark of Murraya koenigii (curryleaf tree). Bismahanine is found in herbs and spices.

Opiorphin

(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-5-carbamimidamido-1-hydroxypentylidene]amino}-1-hydroxy-3-phenylpropylidene]amino}-1,3-dihydroxypropylidene]amino}-5-carbamimidamidopentanoic acid

C29H48N12O8 (692.3717888)

Opiorphin is an endogenous 5-residue opioid peptide (Gln-Arg-Phe-Ser-Arg) first isolated from human saliva. Initial research with mice shows the compound has a painkilling effect greater than that of morphine. It works by stopping the normal breakdown of enkephalins, natural pain-killing opioids in the spinal cord. Opiorphin originates from the N-terminal region of the protein PROL1 (proline rich, lacrimal 1) and inhibits three proteases: neutral ecto-endopeptidase (MME), ecto-aminopeptidase N (ANPEP) and a dipeptidyl peptidase DPP3. This protease inhibitory action extends the duration of enkephalins, which are natural pain killers that are released in response to specific potentially painful stimuli. Opiorphin, an opioid peptide, is a potent enkephalin-inactivating zinc ectopeptidases in human inhibitor. Opiorphin inhibits two enkephalin-catabolizing ectoenzymes, human neutral ecto-endopeptidase, hNEP (EC 3.4.24.11) with an IC50 value of 11 μM, and human ecto-aminopeptidase, hAP-N (EC 3.4.11.2). Opiorphin displays potent analgesic activity by activating endogenous opioid-dependent transmission[1][2].

beta-Casomorphin-7

2-[(2-{[(1-{2-[({1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-3-phenylpropanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-1-hydroxyethylidene)amino]-3-methylpentanoate

C36H48N6O8 (692.3533448000001)

(18R)-18-O-beta-D-glucopyranosyl-(1-2)-beta-D-glucopyranoside of allo-murolic acid

C33H56O15 (692.3619026)

(18S)-18-O-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranoside of protoconstipatic acid

C33H56O15 (692.3619026)

(18R)-18-O-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranoside of murolic acid

C33H56O15 (692.3619026)

Antibiotic A 54556C

C36H48N6O8 (692.3533448000001)

lytophilippine A

C34H57ClO12 (692.3538352)

19-[(1S,4R)-4-hydroxy-1-methoxy-2-oxopentyl]-4,5-dihydrogeldanamycin

C35H52N2O12 (692.3520072)

bispyrayafoline

C46H48N2O4 (692.3613888)

3,3,5,8-Tetramethyl-3,3-bis(4-methyl-3-pentenyl)-9,9-dihydroxy-3,3,11,11-tetrahydro-8,10-bi[pyrano[3,2-a]carbazole]

C46H48N2O4 (692.3613888)

Bismahanine

13-[9-hydroxy-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-3H,11H-pyrano[3,2-a]carbazol-10-yl]-5,8-dimethyl-5-(4-methylpent-3-en-1-yl)-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaen-14-ol

C46H48N2O4 (692.3613888)

N,N-(methylenedi-p-phenylene)bis[N-[3-(triethoxysilyl)propyl]urea]

C33H56N4O8Si2 (692.3636496)

Acylsucrose S4:21 [3]*

C33H56O15 (692.3619026)

Sucrose-2-(2-methyl)butyryl-4-(2-methyl)butyryl-3-(4-methyl)hexanoyl-6-isobutyrate

C33H56O15 (692.3619026)

H-DL-Tyr-DL-Pro-DL-Phe-DL-Pro-Gly-DL-xiIle-OH

C36H48N6O8 (692.3533448000001)

[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C33H56O15 (692.3619026)

[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C33H57O13P (692.3536601999999)

[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C33H57O13P (692.3536601999999)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-octanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C33H57O13P (692.3536601999999)

[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C33H57O13P (692.3536601999999)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C37H57O10P (692.3689152)

Opiorphin

C29H48N12O8 (692.3717888)

Opiorphin, an opioid peptide, is a potent enkephalin-inactivating zinc ectopeptidases in human inhibitor. Opiorphin inhibits two enkephalin-catabolizing ectoenzymes, human neutral ecto-endopeptidase, hNEP (EC 3.4.24.11) with an IC50 value of 11 μM, and human ecto-aminopeptidase, hAP-N (EC 3.4.11.2). Opiorphin displays potent analgesic activity by activating endogenous opioid-dependent transmission[1][2].